Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
3,978
-189,565
-98% -$17.3M 0.02% 134
2026
Q1
$19.9M Buy
193,543
+63,383
+49% +$7.16M 1.37% 21
2025
Q4
$16.3M Buy
130,160
+564
+0.4% +$71.9K 1.04% 33
2025
Q3
$17.4M Buy
129,596
+3,723
+3% +$489K 1.1% 30
2025
Q2
$17.1M Buy
+125,873
New +$16.6M 1.84% 25

Other funds holding ABT

DDD Partners's ABT Position: Q2 2026 in Review

DDD Partners reduced its Abbott (ABT) stake by 98% in Q2 2026, selling an estimated $17.3M and leaving 3,978 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #134.

DDD Partners first reported a position in ABT in Q2 2025 and has held it in 5 quarters since. The position peaked at $19.9M in Q1 2026. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • DDD Partners held 3,978 shares of Abbott worth $361K as of Q2 2026.
  • DDD Partners sold 189,565 Abbott shares in Q2 2026, an estimated $17.3M.
  • Abbott made up 0.02% of DDD Partners's portfolio in Q2 2026, its #134 holding.
  • DDD Partners first reported a position in Abbott in Q2 2025 and has held it in 5 quarters since.
  • DDD Partners's Abbott position peaked at $19.9M in Q1 2026.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on DDD Partners's 13F filing for Q2 2026, filed 5 Aug 2026.